Centrum Medyczne Enel Med SA

  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: PLENLMD00017
PLN
19.20
-0.1 (-0.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROCE of 1.80%

  • The company has been able to generate a Return on Capital Employed (avg) of 1.80% signifying low profitability per unit of total capital (equity and debt)
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

Poor long term growth as Operating profit has grown by an annual rate 50.66% of over the last 5 years

 
4

With ROE of 8.29%, it has a expensive valuation with a 2.97 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Insurance

stock-summary
Market cap

PLN 650 Million (Small Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

7.96%

stock-summary
Price to Book

3.54

Revenue and Profits:
Net Sales:
215 Million
(Quarterly Results - Sep 2025)
Net Profit:
7 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.67%
0%
6.67%
6 Months
6.08%
0%
6.08%
1 Year
-3.52%
0%
-3.52%
2 Years
3.78%
0%
3.78%
3 Years
40.15%
0%
40.15%
4 Years
17.79%
0%
17.79%
5 Years
16.36%
0%
16.36%

Centrum Medyczne Enel Med SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
12.00%
EBIT Growth (5y)
50.66%
EBIT to Interest (avg)
-0.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
16.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.80%
ROE (avg)
0.70%

Valuation key factors

Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
2.97
EV to EBIT
23.50
EV to EBITDA
5.47
EV to Capital Employed
2.81
EV to Sales
0.73
PEG Ratio
0.43
Dividend Yield
NA
ROCE (Latest)
11.98%
ROE (Latest)
8.29%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 3.11% vs 1.95% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 370.37% vs -143.55% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "215.20",
          "val2": "208.70",
          "chgp": "3.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.80",
          "val2": "20.80",
          "chgp": "57.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "2.30",
          "chgp": "17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.30",
          "val2": "-2.70",
          "chgp": "370.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "55.50%",
          "val2": "3.10%",
          "chgp": "5.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.26% vs 24.63% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 84.81% vs 133.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "735.60",
          "val2": "616.80",
          "chgp": "19.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "98.40",
          "val2": "68.10",
          "chgp": "44.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.40",
          "val2": "10.20",
          "chgp": "1.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "3.60",
          "chgp": "-155.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.60",
          "val2": "7.90",
          "chgp": "84.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.10%",
          "val2": "-6.20%",
          "chgp": "3.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
215.20
208.70
3.11%
Operating Profit (PBDIT) excl Other Income
32.80
20.80
57.69%
Interest
2.70
2.30
17.39%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.30
-2.70
370.37%
Operating Profit Margin (Excl OI)
55.50%
3.10%
5.24%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 3.11% vs 1.95% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 370.37% vs -143.55% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
735.60
616.80
19.26%
Operating Profit (PBDIT) excl Other Income
98.40
68.10
44.49%
Interest
10.40
10.20
1.96%
Exceptional Items
-2.00
3.60
-155.56%
Consolidate Net Profit
14.60
7.90
84.81%
Operating Profit Margin (Excl OI)
31.10%
-6.20%
3.73%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 19.26% vs 24.63% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 84.81% vs 133.47% in Dec 2023

stock-summaryCompany CV
About Centrum Medyczne Enel Med SA stock-summary
stock-summary
Centrum Medyczne Enel Med SA
Insurance
Centrum Medyczne Enel-Med SA is a Poland-based company that provides medical services. The Company provides medical care for individuals or families, as well as medical care for entire companies. Among the Company’s services are specialist consultations, dental services, imaging diagnostics, rehabilitation, psychological centre, ophthalmological outpatient clinic, hypertensiology clinic, apnea diagnostics and treatment outpatient clinic, insomnia treatment clinic, sarcoidosis outpatient clinic, aesthetic medicine and others. Its centers are located in Warsaw, Poznan, Lodz and other Polish cities. The Company’s divisions and diagnostic laboratories are located in Warsaw, Lublin, Mielec and Poznan, among others. The Company's subsidiaries include Enel Invest Sp z o o and Enelbud Sp z o o.
Company Coordinates stock-summary
Company Details
Ul. Slominskiego 19 lok. 524 , WARSZAWA None : 00-195
stock-summary
Tel: 48 22 431770148 22 4317701
stock-summary
Registrar Details